[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Functional (Non Ulcer) Dyspepsia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 109 pages | ID: 2EEE5ED3EF1EN
VPAResearch

US$ 1,799.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global clinical trial report- “2019 Functional (Non Ulcer) Dyspepsia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Functional (Non Ulcer) Dyspepsia. It presents in-depth analysis of Functional (Non Ulcer) Dyspepsia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Functional (Non Ulcer) Dyspepsia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Functional (Non Ulcer) Dyspepsia clinical trials by-
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Functional (Non Ulcer) Dyspepsia

The research work is prepared through extensive and continuous research on Functional (Non Ulcer) Dyspepsia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Functional (Non Ulcer) Dyspepsia patients are identified
  • The report includes panorama of Functional (Non Ulcer) Dyspepsia clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Functional (Non Ulcer) Dyspepsia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Functional (Non Ulcer) Dyspepsia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Functional (Non Ulcer) Dyspepsia Clinical Trials by Region
  2.2.2 Average Enrollment of Functional (Non Ulcer) Dyspepsia Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Functional (Non Ulcer) Dyspepsia Treatment, 2019

3. REGION WISE FUNCTIONAL (NON ULCER) DYSPEPSIA CLINICAL TRIALS

3.1 Asia Pacific Functional (Non Ulcer) Dyspepsia Clinical Trials by Country
3.2 Europe Functional (Non Ulcer) Dyspepsia Clinical Trials by Country
3.3 North America Functional (Non Ulcer) Dyspepsia Clinical Trials by Country
3.4 Middle East and Africa Functional (Non Ulcer) Dyspepsia Clinical Trials by Country
3.5 South and Central America Functional (Non Ulcer) Dyspepsia Clinical Trials by Country

4. FUNCTIONAL (NON ULCER) DYSPEPSIA CLINICAL TRIAL TRENDS

4.1 Start Year wise Functional (Non Ulcer) Dyspepsia Clinical Trials
4.2 Phase wise Functional (Non Ulcer) Dyspepsia Clinical Trials
4.3 Trial Status wise Functional (Non Ulcer) Dyspepsia Clinical Trials
4.4 Trial Type wise Functional (Non Ulcer) Dyspepsia Clinical Trials

5. FUNCTIONAL (NON ULCER) DYSPEPSIA AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Functional (Non Ulcer) Dyspepsia Trials by Year
5.2 Average Enrollment in Functional (Non Ulcer) Dyspepsia Trials by Phase
5.3 Average Enrollment in Functional (Non Ulcer) Dyspepsia Trials by Status
5.4 Average Enrollment in Functional (Non Ulcer) Dyspepsia Trials by Type of Trial

6. COMPANIES PARTICIPATING IN FUNCTIONAL (NON ULCER) DYSPEPSIA CLINICAL TRIALS

6.1 Functional (Non Ulcer) Dyspepsia Trials by Sponsor Type
6.2 Functional (Non Ulcer) Dyspepsia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Functional (Non Ulcer) Dyspepsia Trials- Phase
7.2 Functional (Non Ulcer) Dyspepsia Trials- Phase
7.3 Functional (Non Ulcer) Dyspepsia Trials- Phase
7.4 Functional (Non Ulcer) Dyspepsia Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Functional (Non Ulcer) Dyspepsia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Figure 5: Europe – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Figure 7: North America – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Figure 9: Functional (Non Ulcer) Dyspepsia Clinical Trials by Phase
Figure 10: Functional (Non Ulcer) Dyspepsia Clinical Trials by Trial Status
Figure 11: Functional (Non Ulcer) Dyspepsia Clinical Trials by Type
Figure 12: Functional (Non Ulcer) Dyspepsia Clinical Trials by Sponsor Type
Figure 13: Functional (Non Ulcer) Dyspepsia Clinical Trials by Leading Sponsors
Figure 14: Functional (Non Ulcer) Dyspepsia Average Enrollment by Phase
Figure 15: Functional (Non Ulcer) Dyspepsia Average Enrollment by Trial Status
Figure 16: Functional (Non Ulcer) Dyspepsia Average Enrollment by Type
Figure 17: Functional (Non Ulcer) Dyspepsia- Average Enrolment by Type of Sponsors
Figure 18: Functional (Non Ulcer) Dyspepsia- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Functional (Non Ulcer) Dyspepsia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Table 5: Europe – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Table 7: North America – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Functional (Non Ulcer) Dyspepsia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Functional (Non Ulcer) Dyspepsia Average Enrollment by Phase
Table 15: Functional (Non Ulcer) Dyspepsia Average Enrollment by Trial Status
Table 16: Functional (Non Ulcer) Dyspepsia Average Enrollment by Type
Table 17: Functional (Non Ulcer) Dyspepsia- Average Enrolment by Type of Sponsors
Table 18: Functional (Non Ulcer) Dyspepsia- Enrolment by Leading Sponsors


More Publications